Effect of Treatment of Central Sleep Apnea/Cheyne-Stokes Respiration on Left Ventricular Ejection Fraction in Heart Failure: A Network Meta-Analysis
Author(s) -
Esther I. Schwarz,
Frank Scherff,
Sarah R. Haile,
Joerg Steier,
Malcolm Kohler
Publication year - 2019
Publication title -
journal of clinical sleep medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 92
eISSN - 1550-9397
pISSN - 1550-9389
DOI - 10.5664/jcsm.8092
Subject(s) - cheyne–stokes respiration , ejection fraction , medicine , heart failure , continuous positive airway pressure , central sleep apnea , cardiology , randomized controlled trial , apnea–hypopnea index , sleep apnea , positive airway pressure , confidence interval , meta analysis , obstructive sleep apnea , apnea , polysomnography
Patients who have experienced heart failure with central sleep apnea/Cheyne-Stokes respiration (CSA/CSR) have an impaired prognosis. Continuous positive airway pressure (CPAP) and adaptive servoventilation (ASV) as well as nocturnal oxygen (O₂) are proposed treatment modalities of CSA/CSR. The goal of the study is to assess whether and how different treatments of CSA/CSR affect cardiac function.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom